M&A Deal Summary

Lee Biosolutions Acquires Creative Laboratory Products

On March 25, 2016, Lee Biosolutions acquired life science company Creative Laboratory Products

Acquisition Highlights
  • This is Lee Biosolutions’ 1st transaction in the Life Science sector.
  • This is Lee Biosolutions’ 1st transaction in the United States.
  • This is Lee Biosolutions’ 1st transaction in Indiana.

M&A Deal Summary

Date 2016-03-25
Target Creative Laboratory Products
Sector Life Science
Buyer(s) Lee Biosolutions
Deal Type Add-on Acquisition

Target

Creative Laboratory Products

Indianapolis, Indiana, United States
Creative Laboratory Products, Inc. is a producer of human and animal cholesterol concentrates, such as low density lipoprotein (LDL), high density lipoprotein(HDL) and delipidized serum products.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Lee Biosolutions

Maryland Heights, Missouri, United States

Category Company
Founded 1975
Sector Life Science
DESCRIPTION

Lee Biosolutions, Inc. is a biotechnology provider specializing in custom and bulk manufacturing and preparation of high quality finished enzymes, related proteins and biologicals used in clinical diagnostic tests for pathologies such as cardiac disease, cancer, diabetes, urine analysis, obesity, inflammation, neurological, autoimmune diseases, immunological disorders and more.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Indiana M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1